The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction
ANGIO-STEMI
1 other identifier
observational
80
1 country
1
Brief Summary
This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedFirst Submitted
Initial submission to the registry
August 31, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 5, 2024
CompletedSeptember 19, 2024
September 1, 2024
6 months
August 31, 2024
September 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Major Adverse Cardiovascular Events (MACE)
During hospitalization, up to 1 weeks
Secondary Outcomes (6)
Incidence of mortality
During hospitalization, up to 1 weeks
Incidence of reinfarction
During hospitalization, up to 1 weeks
Incidence of stroke
During hospitalization, up to 1 weeks
Incidence of lethal arrhythmia
During hospitalization, up to 1 weeks
Incidence of acute lung oedema
During hospitalization, up to 1 weeks
- +1 more secondary outcomes
Study Arms (1)
MACE group
Patient with STEMI who suffered major adverse cardiovascular events (MACE) after underwent primary percutaneous coronary intervention (PPCI)
Interventions
Eligibility Criteria
Patient with ST-segment elevation myocardial infarction who underwent PPCI
You may qualify if:
- Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI
You may not qualify if:
- History of heart failure due to any causes
- Cardiogenic shock before PPCI
- Any infection at the time of presentation
- Pregnant woman
- Other causes of high anion gap levels such as chronic kidney disease, metabolic acidosis, etc
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Kariadi Central General Hospital
Semarang, Central of Java, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 7 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator; Former of Head of Department of Cardiovascular Medicine Faculty of Medicine Universitas Diponegoro
Study Record Dates
First Submitted
August 31, 2024
First Posted
September 19, 2024
Study Start
January 1, 2024
Primary Completion
June 30, 2024
Study Completion
October 5, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share